Clinical Trials Browser

Phase 1/2 × Waldenstrom Macroglobulinemia × alethine × Clear all

NCT00041379 2013-12-18

Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia

Phase 1/2 Unknown

Lymphoma, Waldenstrom Macroglobulinemia